Literature DB >> 28108094

Metabolic profiling identification of metabolites formed in Mediterranean mussels (Mytilus galloprovincialis) after diclofenac exposure.

Bénilde Bonnefille1, Lauren Arpin-Pont1, Elena Gomez1, Hélène Fenet1, Frédérique Courant2.   

Abstract

Despite the growing concern on the presence of pharmaceutically active compounds in the environment, few studies have been conducted on their metabolism in marine organisms. In this study, a non-targeted strategy based on the generation of chemical profiles generated by liquid chromatography combined with high resolution mass spectrometry was used to highlight metabolite production by the Mediterranean mussel (Mytilus galloprovincialis) after diclofenac exposure. This method allowed revealing the production of 13 metabolites in mussel tissues. Three of them were phase I metabolites, including 4'-hydroxy-diclofenac and 5-hydroxy-diclofenac. The remaining 10 were phase II metabolites, including sulfate and amino acids conjugates. Among all of the metabolites highlighted, 5 were reported for the first time in an aquatic organism exposed to diclofenac.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aquatic organism; LC-HRMS; Metabolism; NSAID; Non-targeted strategy

Mesh:

Substances:

Year:  2017        PMID: 28108094     DOI: 10.1016/j.scitotenv.2017.01.063

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  2 in total

1.  Exposure of marine mussels to diclofenac: modulation of prostaglandin biosynthesis.

Authors:  Frédérique Courant; Lauren Arpin-Pont; Bénilde Bonnefille; Sébastien Vacher; Marina Picot-Groz; Elena Gomez; Hélène Fenet
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-21       Impact factor: 4.223

2.  Forensic tracers of exposure to produced water in freshwater mussels: a preliminary assessment of Ba, Sr, and cyclic hydrocarbons.

Authors:  Paulina K Piotrowski; Travis L Tasker; Thomas J Geeza; Bonnie McDevitt; David P Gillikin; Nathaniel R Warner; Frank L Dorman
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.